GO
Loading...

Celgene Corp

More

  • Early Glance: Biotechnology companies Friday, 11 Jul 2014 | 10:30 AM ET

    Amgen Inc. rose$. 37 or. 3 percent, to $119.32. Biogen Idec fell $1.42 or. 4 percent, to $317.70. Celgene Corp. fell$. 05 or. 1 percent, to $87.78.

  • Midday Glance: Biotechnology companies Thursday, 10 Jul 2014 | 1:44 PM ET

    Amgen Inc. fell$. 81 or. 7 percent, to $118.76. Biogen Idec fell$. 39 or. 1 percent, to $319.75. Celgene Corp. rose$. 72 or. 8 percent, to $88.24.

  • Early Glance: Biotechnology companies Thursday, 10 Jul 2014 | 11:01 AM ET

    Amgen Inc. fell$. 89 or. 7 percent, to $118.68. Biogen Idec fell $3.10 or 1.0 percent, to $317.04. Celgene Corp. fell$. 60 or. 7 percent, to $86.92.

  • Celgene says Otezla falls short in added use study Wednesday, 9 Jul 2014 | 9:25 AM ET

    SUMMIT, N.J.— Shares of Celgene Corp. slipped in premarket trading Wednesday after the drugmaker said its psoriatic arthritis treatment Otezla missed the main goal of a late-stage study exploring an additional use. Celgene said it planned to start another late-stage study after it does more data analysis.

  • July 9- Celgene Corp said a drug being tested to treat a type of arthritis that affects the spine failed to meet the main goal in a late-stage trial, sending the company's shares down 3 percent premarket. Celgene said it would continue the study unchanged based on a recommendation by an independent data monitoring committee.

  • July 9- Celgene Corp said its experimental drug for the treatment of a type of arthritis that affects the spine failed to meet the main goal in a late-stage study, sending its shares down 3 percent premarket.

  • Midday Glance: Biotechnology companies Tuesday, 8 Jul 2014 | 1:41 PM ET

    Amgen Inc. rose$. 06 or percent, to $120.22. Biogen Idec fell $7.60 or 2.3 percent, to $318.08. Celgene Corp. fell $3.01 or 3.4 percent, to $85.86.

  • Early Glance: Biotechnology companies Tuesday, 8 Jul 2014 | 10:30 AM ET

    Amgen Inc. fell$. 10 or. 1 percent, to $120.06. Biogen Idec fell $4.43 or 1.4 percent, to $321.25. Celgene Corp. fell $1.39 or 1.6 percent, to $87.48.

  • Final Glance: Biotechnology companies Thursday, 3 Jul 2014 | 5:15 PM ET

    Amgen Inc. rose $1.82 or 1.5 percent, to $122.85. Biogen Idec rose$. 15 or percent, to $331.15. Celgene Corp. rose$. 12 or. 1 percent, to $90.19.

  • Midday Glance: Biotechnology companies Thursday, 3 Jul 2014 | 1:17 PM ET

    Amgen Inc. rose $1.82 or 1.5 percent, to $122.85. Biogen Idec rose$. 15 or percent, to $331.15. Celgene Corp. rose$. 12 or. 1 percent, to $90.19.

  • FDA approves Spectrum Pharma's blood cancer drug Thursday, 3 Jul 2014 | 11:19 AM ET

    July 3- Spectrum Pharmaceuticals Inc's drug for the treatment of an aggressive form of blood cancer was granted an accelerated approval by the U.S. Food and Drug Administration on Thursday. Beleodaq is the third drug to win approval for the condition since 2009, the other two being Spectrum's injection Folotyn and Celgene Corp's drug Istodax.

  • Early Glance: Biotechnology companies Thursday, 3 Jul 2014 | 10:30 AM ET

    Amgen Inc. fell$. 15 or. 1 percent, to $120.88. Biogen Idec fell $1.90 or. 6 percent, to $329.10. Celgene Corp. fell$. 79 or. 9 percent, to $89.28.

  • Look for more upside in these biotech names: Pro Tuesday, 24 Jun 2014 | 2:48 PM ET

    Vertex Pharmaceuticals' spike Tuesday had investors looking for the next breakout stock. UBS's Matt Roden likes these names.

  • Midday movers: Coach, Kroger, Markit & More Thursday, 19 Jun 2014 | 12:38 PM ET
    A trader works on the floor of the New York Stock Exchange.

    Some of Thursday's midday movers:

  • Beleaguered biotechs about to rally: Charts Wednesday, 4 Jun 2014 | 6:26 PM ET

    For the past several months biotech stocks have fallen out of favor on Wall Street. That may be about to change.

  • Midday movers: Apple, Astrotech, Blackberry & More Thursday, 29 May 2014 | 12:20 PM ET
    A trader works on the floor of the New York Stock Exchange.

    Some of Thursday's midday movers:

  • Midday movers: NFLX, PCLN, BIIB & more Thursday, 15 May 2014 | 12:23 PM ET
    NYSE exchange floor

    Take a look at some of Thursday's midday movers:

  • Midday movers: Aaron's, Eli Lilly, Gogo & More Monday, 12 May 2014 | 12:30 PM ET
    NYSE EuroNext flag hangs outside the NYSE.

    Some of Monday's midday movers:

  • No respect! Market not rewarding good earnings Friday, 25 Apr 2014 | 10:28 AM ET
    A trader works on the floor of the New York Stock Exchange.

    This quarter's earnings have a clear trend: they either beat expectations or report in-line, which does little to help the stock.

  • Cramer: Don’t give up on Facebook and friends Thursday, 24 Apr 2014 | 6:20 PM ET

    For one reason or another it appears the market is giving up on these stocks. Jim Cramer isn't.